Latest News

Pharma2b

First Patients Dosed in Phase III Multi-center, Multinational Study to...

Based on positive data from a Phase IIb pivotal study suggesting that P2B001 may offer effective therapy with minimal side...

Pharma2b

Pharma Two B Ltd. Closes $30 Million Financing Round

REHOVOTH, Israel, February 27, 2017 — Pharma Two B Ltd., a privately held biopharmaceutical company focused on developing treatments for...

Stemcell

Exosomes Derived from Human Mesenchymal Stem Cells Ameliorate Autistic-like Behaviors

Stem Cell Medicine Announces Late-Breaking News Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting JERUSALEM Israel, April...